Sign In
Get Clay Free →

Suggestions

    Sean Mackay

    IsoPlexis, Chief Executive Officer and Co-Founder

    Sean Mackay is the CEO and co-founder of IsoPlexis, a company focused on providing innovative cellular proteomics to enable personalized and curative medicines.

    Previously, Sean contributed to the development of Lifesquare, a healthcare information platform supported by Kleiner Perkins, and gained experience in strategic management within life sciences and medical device companies.

    With a strong educational background in Economics from The Wharton School and an MBA from Yale School of Management, Sean Mackay brings a wealth of knowledge and expertise to the biotechnology industry.

    His work at IsoPlexis revolves around revolutionary technologies in cell and gene therapy, cancer immunology, and infectious disease, aiming to enhance patient-specific treatments and advance precision medicine globally.

    Sean Mackay's commitment to innovation and strategic growth is evidenced by his numerous publications on immune medicines and patented single-cell products, establishing him as a prominent figure in the biotech sector.

    Sean Mackay
    Add to my network

    Location

    New Haven, Connecticut, United States